期刊
GENE
卷 826, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.gene.2022.146463
关键词
Broad H3K4me3 domains; Broad H3K4ac domains; Breast cancer; Enhancer; Active histone marks
资金
- Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05927]
- CancerCare Manitoba [761020451]
- ANID/CONICYT-FONDECYT de Iniciacion [11190998]
- ANID-Basal funding for Scientific and Technological Center of Excellence, IMPACT [FB210024]
- CancerCare Manitoba Research Institute
Epigenetic processes are altered in cancer cells, with specific genes showing broad histone modifications associated with breast cancer subtypes. These genes play critical roles in breast cancer and have been targeted in therapeutic treatments.
Epigenetic processes are radically altered in cancer cells. The altered epigenetic events may include histone post translational modifications (PTMs), DNA modifications, and/or alterations in the levels and modifications of chromatin modifying enzymes and chromatin remodelers. With changes in gene programming are changes in the genomic distribution of histone PTMs. Genes that are poised or transcriptionally active have histone H3 trimethylated lysine 4 (H3K4me3) located at the transcription start site and at the 5 '& nbsp;end of the gene. However, a small population of genes that are involved in cell identity or cancer cell properties have a broad H3K4me3 domain that may stretch for several kilobases through the coding region of the gene. Each cancer cell type appears to mark a select set of cancer-related genes in this manner. In this study, we determined which genes were differentially marked with the broad H3K4me3 domain in normal-like (MCF10A), luminal-type breast cancer (MCF7), and triple-negative breast cancer (MDA-MB-231) cells. We also determined whether histone H3 acetylated lysine 4 (H3K4ac), also a mark of active promoters, had a broad domain configuration. We applied two peak callers (MACS2, PeakRanger) to analyze H3K4me3 and H3K4ac chromatin immunoprecipitation sequencing (ChIP-Seq) data. We identified genes with a broad H3K4me3 and/or H3K4ac domain specific to each cell line and show that the genes have critical roles in the breast cancer subtypes. Furthermore, we show that H3K4ac marks enhancers. The identified genes with the broad H3K4me3/H3K4ac domain have been targeted in clinical and pre-clinical studies including therapeutic treatments of breast cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据